ASX - By Stock
|
IMU |
Re:
Ann: Imugene HER-Vaxx Immunotherapy Patent Granted in Japan
|
|
EML333
|
187 |
96K |
4 |
22/09/21 |
22/09/21 |
ASX - By Stock
|
187
|
96K
|
4
|
|
ASX - By Stock
|
WBT |
Re:
Ann: Weebit signs first commercial deal with US-based SkyWater
|
|
EML333
|
698 |
280K |
3 |
09/09/21 |
09/09/21 |
ASX - By Stock
|
698
|
280K
|
3
|
|
ASX - By Stock
|
WBT |
Re:
Ann: Weebit signs first commercial deal with US-based SkyWater
|
|
EML333
|
698 |
280K |
10 |
09/09/21 |
09/09/21 |
ASX - By Stock
|
698
|
280K
|
10
|
|
ASX - By Stock
|
WBT |
Re:
Ann: Weebit signs first commercial deal with US-based SkyWater
|
|
EML333
|
698 |
280K |
1 |
09/09/21 |
09/09/21 |
ASX - By Stock
|
698
|
280K
|
1
|
|
ASX - By Stock
|
WBT |
Re:
Ann: Weebit signs first commercial deal with US-based SkyWater
|
|
EML333
|
698 |
280K |
5 |
09/09/21 |
09/09/21 |
ASX - By Stock
|
698
|
280K
|
5
|
|
ASX - By Stock
|
AN1 |
Re:
Covid-19 Rapid testing kits
|
|
EML333
|
30 |
6.4K |
0 |
06/09/21 |
06/09/21 |
ASX - By Stock
|
30
|
6.4K
|
0
|
|
ASX - By Stock
|
AN1 |
Re:
Covid-19 Rapid testing kits
|
|
EML333
|
30 |
6.4K |
0 |
06/09/21 |
06/09/21 |
ASX - By Stock
|
30
|
6.4K
|
0
|
|
ASX - By Stock
|
WBT |
Re:
Ann: Application for quotation of securities - WBT
|
|
EML333
|
62 |
25K |
7 |
06/09/21 |
06/09/21 |
ASX - By Stock
|
62
|
25K
|
7
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Trading Halt
|
|
EML333
|
414 |
202K |
6 |
27/07/21 |
27/07/21 |
ASX - By Stock
|
414
|
202K
|
6
|
|
ASX - By Stock
|
WBT |
Re:
Wbt competitors.
|
|
EML333
|
122 |
54K |
0 |
19/07/21 |
19/07/21 |
ASX - By Stock
|
122
|
54K
|
0
|
|
ASX - By Stock
|
WBT |
Re:
Wbt competitors.
|
|
EML333
|
122 |
54K |
0 |
19/07/21 |
19/07/21 |
ASX - By Stock
|
122
|
54K
|
0
|
|
ASX - By Stock
|
WBT |
Re:
Wbt competitors.
|
|
EML333
|
122 |
54K |
0 |
19/07/21 |
19/07/21 |
ASX - By Stock
|
122
|
54K
|
0
|
|
ASX - By Stock
|
WBT |
Re:
Weebit - 2021and beyond
|
|
EML333
|
10K |
3.6M |
3 |
19/07/21 |
19/07/21 |
ASX - By Stock
|
10K
|
3.6M
|
3
|
|
ASX - By Stock
|
WBT |
Re:
Charts
|
|
EML333
|
4.9K |
2.0M |
7 |
15/07/21 |
15/07/21 |
ASX - By Stock
|
4.9K
|
2.0M
|
7
|
|
ASX - By Stock
|
IMU |
Re:
Ann: FDA IND APPROVAL OF NEW ONCOLYTIC VIROTHERAPY CHECKVACC
|
|
EML333
|
246 |
136K |
11 |
02/07/21 |
02/07/21 |
ASX - By Stock
|
246
|
136K
|
11
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Change of Director's Interest Notice - LC
|
|
EML333
|
73 |
33K |
7 |
27/05/21 |
27/05/21 |
ASX - By Stock
|
73
|
33K
|
7
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Change of Director's Interest Notice - LC
|
|
EML333
|
73 |
33K |
9 |
25/05/21 |
25/05/21 |
ASX - By Stock
|
73
|
33K
|
9
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
EML333
|
24K |
12M |
14 |
20/05/21 |
20/05/21 |
ASX - By Stock
|
24K
|
12M
|
14
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
EML333
|
24K |
12M |
12 |
20/05/21 |
20/05/21 |
ASX - By Stock
|
24K
|
12M
|
12
|
|
ASX - By Stock
|
WBT |
Re:
Charts
|
|
EML333
|
4.9K |
2.0M |
4 |
11/05/21 |
11/05/21 |
ASX - By Stock
|
4.9K
|
2.0M
|
4
|
|
ASX - By Stock
|
WBT |
Re:
Charts
|
|
EML333
|
4.9K |
2.0M |
0 |
10/05/21 |
10/05/21 |
ASX - By Stock
|
4.9K
|
2.0M
|
0
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Final Highest Dose in Phase 1 Clinical Trial of PD-VAXX
|
|
EML333
|
265 |
141K |
7 |
07/04/21 |
07/04/21 |
ASX - By Stock
|
265
|
141K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast Investor losses
|
|
EML333
|
83 |
23K |
1 |
09/03/21 |
09/03/21 |
ASX - By Stock
|
83
|
23K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast Investor losses
|
|
EML333
|
83 |
23K |
5 |
09/03/21 |
09/03/21 |
ASX - By Stock
|
83
|
23K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast Investor losses
|
|
EML333
|
83 |
23K |
2 |
09/03/21 |
09/03/21 |
ASX - By Stock
|
83
|
23K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast Investor losses
|
|
EML333
|
83 |
23K |
5 |
09/03/21 |
09/03/21 |
ASX - By Stock
|
83
|
23K
|
5
|
|
ASX - By Stock
|
WBT |
Re:
Charts
|
|
EML333
|
4.9K |
2.0M |
0 |
05/03/21 |
05/03/21 |
ASX - By Stock
|
4.9K
|
2.0M
|
0
|
|
ASX - By Stock
|
WBT |
Re:
Charts
|
|
EML333
|
4.9K |
2.0M |
2 |
05/03/21 |
05/03/21 |
ASX - By Stock
|
4.9K
|
2.0M
|
2
|
|
ASX - By Stock
|
WBT |
Re:
Charts
|
|
EML333
|
4.9K |
2.0M |
7 |
05/03/21 |
05/03/21 |
ASX - By Stock
|
4.9K
|
2.0M
|
7
|
|
ASX - By Stock
|
WBT |
Re:
Ann: Change of Director's Interest Notice - Yoav Nissan-Cohen
|
|
EML333
|
158 |
42K |
0 |
11/02/21 |
11/02/21 |
ASX - By Stock
|
158
|
42K
|
0
|
|
ASX - By Stock
|
SOR |
Re:
Ann: SOR Turns Brain Inspired Hardware to Robotics
|
|
EML333
|
105 |
28K |
6 |
03/02/21 |
03/02/21 |
ASX - By Stock
|
105
|
28K
|
6
|
|
ASX - By Stock
|
WBT |
Re:
Charts
|
|
EML333
|
4.9K |
2.0M |
1 |
01/02/21 |
01/02/21 |
ASX - By Stock
|
4.9K
|
2.0M
|
1
|
|
ASX - By Stock
|
WBT |
Re:
Ann: Weebit Nano Q2 FY21 Activities Report and Appendix 4C
|
|
EML333
|
132 |
43K |
0 |
29/01/21 |
29/01/21 |
ASX - By Stock
|
132
|
43K
|
0
|
|
ASX - By Stock
|
WBT |
Re:
Ann: Weebit Nano Q2 FY21 Activities Report and Appendix 4C
|
|
EML333
|
132 |
43K |
7 |
29/01/21 |
29/01/21 |
ASX - By Stock
|
132
|
43K
|
7
|
|
ASX - By Stock
|
WBT |
Re:
Ann: Weebit Nano Q2 FY21 Activities Report and Appendix 4C
|
|
EML333
|
132 |
43K |
4 |
29/01/21 |
29/01/21 |
ASX - By Stock
|
132
|
43K
|
4
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene Dose Escalates in PD1-VAXX Phase 1 Clinical Trial
|
|
EML333
|
302 |
161K |
6 |
22/01/21 |
22/01/21 |
ASX - By Stock
|
302
|
161K
|
6
|
|
ASX - By Stock
|
WBT |
Re:
Weebit - 2021and beyond
|
|
EML333
|
10K |
3.6M |
13 |
21/01/21 |
21/01/21 |
ASX - By Stock
|
10K
|
3.6M
|
13
|
|
ASX - By Stock
|
WBT |
Re:
Weebit - 2021and beyond
|
|
EML333
|
10K |
3.6M |
1 |
21/01/21 |
21/01/21 |
ASX - By Stock
|
10K
|
3.6M
|
1
|
|
ASX - By Stock
|
WBT |
Re:
Weebit - 2021and beyond
|
|
EML333
|
10K |
3.6M |
4 |
21/01/21 |
21/01/21 |
ASX - By Stock
|
10K
|
3.6M
|
4
|
|
ASX - By Stock
|
WBT |
Re:
Weebit - 2021and beyond
|
|
EML333
|
10K |
3.6M |
3 |
21/01/21 |
21/01/21 |
ASX - By Stock
|
10K
|
3.6M
|
3
|
|
ASX - By Stock
|
SOR |
Re:
future movement
|
|
EML333
|
125 |
49K |
3 |
21/01/21 |
21/01/21 |
ASX - By Stock
|
125
|
49K
|
3
|
|
ASX - By Stock
|
WBT |
Re:
Weebit - 2021and beyond
|
|
EML333
|
10K |
3.6M |
6 |
20/01/21 |
20/01/21 |
ASX - By Stock
|
10K
|
3.6M
|
6
|
|
ASX - By Stock
|
SOR |
Re:
Technicals
|
|
EML333
|
1.0K |
356K |
7 |
20/01/21 |
20/01/21 |
ASX - By Stock
|
1.0K
|
356K
|
7
|
|
ASX - By Stock
|
SOR |
Re:
Technicals
|
|
EML333
|
1.0K |
356K |
1 |
20/01/21 |
20/01/21 |
ASX - By Stock
|
1.0K
|
356K
|
1
|
|
ASX - By Stock
|
WBT |
Re:
Charts
|
|
EML333
|
4.9K |
2.0M |
9 |
15/01/21 |
15/01/21 |
ASX - By Stock
|
4.9K
|
2.0M
|
9
|
|
ASX - By Stock
|
WBT |
Re:
Charts
|
|
EML333
|
4.9K |
2.0M |
9 |
15/01/21 |
15/01/21 |
ASX - By Stock
|
4.9K
|
2.0M
|
9
|
|
ASX - By Stock
|
SOR |
Re:
Technicals
|
|
EML333
|
1.0K |
356K |
0 |
15/01/21 |
15/01/21 |
ASX - By Stock
|
1.0K
|
356K
|
0
|
|
ASX - By Stock
|
SOR |
Re:
Technicals
|
|
EML333
|
1.0K |
356K |
1 |
15/01/21 |
15/01/21 |
ASX - By Stock
|
1.0K
|
356K
|
1
|
|
ASX - By Stock
|
WBT |
Re:
Weebit - 2021and beyond
|
|
EML333
|
10K |
3.6M |
21 |
08/01/21 |
08/01/21 |
ASX - By Stock
|
10K
|
3.6M
|
21
|
|
ASX - By Stock
|
WBT |
Re:
Weebit - 2021and beyond
|
|
EML333
|
10K |
3.6M |
10 |
08/01/21 |
08/01/21 |
ASX - By Stock
|
10K
|
3.6M
|
10
|
|